T2 Biosystems Inc. hired the Cambridge, U.K.-based consulting firm Sagentia to shepherd the development of its portable diagnostics system.
The Cambridge, Mass.-based start-up is developing nano- and miniaturized magnetic resonance-based technology for use in a bench-top instrument for small molecule diagnostics, according to Sagentia.
In May, T2 raised $15 million in a Series C funding round to support the development of the technology.